| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | SPDYE1 SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.06e-17 | 27 | 92 | 10 | GO:0030548 |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | SPDYE1 SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 3.19e-17 | 28 | 92 | 10 | GO:0099602 |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE1 SPDYE17 SPDYE10 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NBEA SPDYE18 SPDYE12 SPDYE11 SPDYE15 SPDYE7P SPDYE3 SPDYE2 SPDYE8 SPDYE21 SPDYE5 SCRIB SPDYE2B SPDYE4 SPDYE6 SPDYE14 SPDYE16 | 8.32e-13 | 873 | 92 | 24 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | SPDYE1 SPDYE17 SPDYE10 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NBEA SPDYE18 SPDYE12 SPDYE11 SPDYE15 SPDYE7P SPDYE3 SPDYE2 SPDYE8 SPDYE21 SPDYE5 SCRIB SPDYE2B SPDYE4 SPDYE6 SPDYE14 SPDYE16 | 7.58e-12 | 969 | 92 | 24 | GO:0019900 |
| GeneOntologyMolecularFunction | retinoic acid binding | 7.94e-06 | 28 | 92 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.98e-05 | 35 | 92 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | SPDYE1 AMH SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 IGSF1 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.55e-05 | 616 | 92 | 12 | GO:0030545 |
| GeneOntologyMolecularFunction | retinoid binding | 7.03e-05 | 48 | 92 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 7.63e-05 | 49 | 92 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.44e-04 | 66 | 92 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.90e-04 | 69 | 92 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.34e-03 | 12 | 92 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.52e-03 | 107 | 92 | 4 | GO:0033293 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 3.06e-16 | 25 | 82 | 9 | GO:0045737 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.02e-15 | 28 | 82 | 9 | GO:1904031 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.55e-10 | 96 | 82 | 9 | GO:0000079 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.24e-10 | 100 | 82 | 9 | GO:1904029 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.16e-09 | 5 | 82 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.46e-09 | 6 | 82 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.46e-09 | 6 | 82 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.46e-09 | 6 | 82 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 4.86e-09 | 193 | 82 | 10 | GO:0071902 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.78e-08 | 10 | 82 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.78e-08 | 10 | 82 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | ROCK2 SPDYE1 NCAPD3 SPDYE7P FEN1 SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 7.07e-08 | 407 | 82 | 12 | GO:0045787 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.61e-07 | 13 | 82 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 6.02e-07 | 5 | 82 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.26e-06 | 350 | 82 | 10 | GO:0045860 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.32e-06 | 21 | 82 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.32e-06 | 21 | 82 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.54e-06 | 358 | 82 | 10 | GO:0071900 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.24e-06 | 26 | 82 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.24e-06 | 26 | 82 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 4.63e-06 | 405 | 82 | 10 | GO:0033674 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 6.99e-06 | 67 | 82 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 9.83e-06 | 34 | 82 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | ROCK2 RALGAPA1 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SCRIB SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.14e-05 | 1028 | 82 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.30e-05 | 12 | 82 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.90e-05 | 40 | 82 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.42e-05 | 490 | 82 | 10 | GO:0051347 |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.80e-05 | 89 | 82 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ROCK2 SPDYE1 NCAPD3 EME1 ZNF274 UBE2U SPDYE7P FEN1 SPDYE3 SPDYE2 SPDYE5 SCRIB SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.98e-05 | 1256 | 82 | 16 | GO:0051726 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 3.65e-05 | 94 | 82 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 3.65e-05 | 94 | 82 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | ROCK2 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 4.09e-05 | 879 | 82 | 13 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | ROCK2 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 4.09e-05 | 879 | 82 | 13 | GO:0010562 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 5.43e-05 | 52 | 82 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 6.21e-05 | 105 | 82 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | ROCK2 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 7.85e-05 | 937 | 82 | 13 | GO:0031401 |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | ROCK2 SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.34e-04 | 724 | 82 | 11 | GO:0001934 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | ROCK2 RALGAPA1 SPDYE1 FLT3 RNF25 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SCRIB SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.39e-04 | 1430 | 82 | 16 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.52e-04 | 611 | 82 | 10 | GO:0045859 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | ROCK2 SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.55e-04 | 780 | 82 | 11 | GO:0042327 |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.74e-04 | 144 | 82 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 3.83e-04 | 686 | 82 | 10 | GO:0043549 |
| GeneOntologyBiologicalProcess | hormone metabolic process | 9.78e-04 | 286 | 82 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, endosome to plasma membrane | 1.00e-03 | 12 | 82 | 2 | GO:0099639 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 1.15e-03 | 115 | 82 | 4 | GO:0035418 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ROCK2 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 OCLN SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.34e-03 | 1421 | 82 | 14 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ROCK2 SPDYE1 FLT3 PTPA DLC1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 OCLN SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.36e-03 | 1423 | 82 | 14 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | SPDYE1 FLT3 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.37e-03 | 810 | 82 | 10 | GO:0051338 |
| Domain | Spy1 | SPDYE1 SPDYE3 SPDYE2 SPDYE21 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.96e-20 | 11 | 85 | 9 | PF11357 |
| Domain | Speedy | SPDYE1 SPDYE3 SPDYE2 SPDYE21 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.96e-20 | 11 | 85 | 9 | IPR020984 |
| Domain | BAGE | 1.99e-09 | 5 | 85 | 4 | IPR012530 | |
| Domain | BAGE | 1.99e-09 | 5 | 85 | 4 | PF08180 | |
| Domain | UDPGT | 2.25e-06 | 21 | 85 | 4 | PF00201 | |
| Domain | UDPGT | 2.25e-06 | 21 | 85 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 2.25e-06 | 21 | 85 | 4 | IPR002213 | |
| Domain | Plexin_cytopl | 7.22e-04 | 9 | 85 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 7.22e-04 | 9 | 85 | 2 | IPR013548 | |
| Domain | Plexin | 7.22e-04 | 9 | 85 | 2 | IPR031148 | |
| Domain | PKD | 1.10e-03 | 11 | 85 | 2 | PS50093 | |
| Domain | PKD_dom | 1.10e-03 | 11 | 85 | 2 | IPR000601 | |
| Domain | - | 1.10e-03 | 11 | 85 | 2 | 2.60.40.670 | |
| Domain | TIL | 1.31e-03 | 12 | 85 | 2 | PF01826 | |
| Domain | C8 | 1.31e-03 | 12 | 85 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.55e-03 | 13 | 85 | 2 | IPR014853 | |
| Domain | C8 | 1.55e-03 | 13 | 85 | 2 | SM00832 | |
| Domain | TIL_dom | 1.80e-03 | 14 | 85 | 2 | IPR002919 | |
| Domain | VWD | 2.36e-03 | 16 | 85 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.36e-03 | 16 | 85 | 2 | IPR001846 | |
| Domain | VWFD | 2.36e-03 | 16 | 85 | 2 | PS51233 | |
| Domain | VWD | 2.36e-03 | 16 | 85 | 2 | PF00094 | |
| Domain | VWC_out | 3.33e-03 | 19 | 85 | 2 | SM00215 | |
| Domain | FA58C | 4.06e-03 | 21 | 85 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.06e-03 | 21 | 85 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.06e-03 | 21 | 85 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.06e-03 | 21 | 85 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 5.29e-03 | 24 | 85 | 2 | PF00754 | |
| Domain | FA58C | 5.29e-03 | 24 | 85 | 2 | IPR000421 | |
| Domain | Cys_knot_C | 5.74e-03 | 25 | 85 | 2 | IPR006207 | |
| Domain | CTCK_2 | 5.74e-03 | 25 | 85 | 2 | PS01225 | |
| Domain | IPT | 6.67e-03 | 27 | 85 | 2 | SM00429 | |
| Domain | - | 7.42e-03 | 169 | 85 | 4 | 3.40.50.720 | |
| Domain | Rho_GTPase_activation_prot | 7.56e-03 | 88 | 85 | 3 | IPR008936 | |
| Domain | NAD(P)-bd_dom | 8.04e-03 | 173 | 85 | 4 | IPR016040 | |
| Domain | TIG | 8.74e-03 | 31 | 85 | 2 | PF01833 | |
| Domain | Sema | 8.74e-03 | 31 | 85 | 2 | SM00630 | |
| Domain | Semap_dom | 8.74e-03 | 31 | 85 | 2 | IPR001627 | |
| Domain | Sema | 8.74e-03 | 31 | 85 | 2 | PF01403 | |
| Domain | SEMA | 8.74e-03 | 31 | 85 | 2 | PS51004 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.66e-06 | 22 | 57 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.40e-06 | 24 | 57 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.85e-06 | 25 | 57 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.85e-06 | 25 | 57 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.85e-06 | 25 | 57 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.36e-06 | 26 | 57 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.57e-06 | 28 | 57 | 4 | M19580 | |
| Pathway | KEGG_RETINOL_METABOLISM | 5.74e-06 | 64 | 57 | 5 | M9488 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.03e-05 | 72 | 57 | 5 | M9257 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.78e-05 | 39 | 57 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.18e-05 | 41 | 57 | 4 | M7399 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.21e-05 | 14 | 57 | 3 | M39328 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.16e-05 | 45 | 57 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.21e-05 | 51 | 57 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.63e-05 | 52 | 57 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.03e-05 | 55 | 57 | 4 | M14933 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM | 1.59e-04 | 5 | 57 | 2 | M47902 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.81e-04 | 70 | 57 | 4 | M16794 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 5.68e-04 | 9 | 57 | 2 | MM15030 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.38e-04 | 44 | 57 | 3 | M45014 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 9.10e-04 | 107 | 57 | 4 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 9.75e-04 | 109 | 57 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 9.75e-04 | 109 | 57 | 4 | M18788 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.03e-03 | 12 | 57 | 2 | M39611 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.14e-03 | 51 | 57 | 3 | MM14967 | |
| Pathway | REACTOME_DRUG_ADME | 1.35e-03 | 119 | 57 | 4 | MM15692 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.42e-03 | 14 | 57 | 2 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.42e-03 | 14 | 57 | 2 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.63e-03 | 15 | 57 | 2 | MM15031 | |
| Pathway | WP_MRNA_PROCESSING | 1.67e-03 | 126 | 57 | 4 | M39406 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.86e-03 | 16 | 57 | 2 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.86e-03 | 16 | 57 | 2 | M8245 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.88e-03 | 219 | 57 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.92e-03 | 220 | 57 | 5 | M10320 | |
| Pathway | WP_RETINOL_METABOLISM | 2.10e-03 | 17 | 57 | 2 | M48311 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.19e-03 | 64 | 57 | 3 | M7923 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 2.63e-03 | 19 | 57 | 2 | M10959 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | SPDYE1 SPDYE17 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 4.50e-24 | 13 | 96 | 10 | 15611625 |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 6.33e-24 | 9 | 96 | 9 | 36272447 |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | SPDYE1 SPDYE17 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 3.03e-22 | 17 | 96 | 10 | 15574121 |
| Pubmed | 8.14e-10 | 6 | 96 | 4 | 12461691 | ||
| Pubmed | 8.14e-10 | 6 | 96 | 4 | 32527940 | ||
| Pubmed | 8.14e-10 | 6 | 96 | 4 | 20297805 | ||
| Pubmed | 8.14e-10 | 6 | 96 | 4 | 12676563 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.90e-09 | 7 | 96 | 4 | 8467709 | |
| Pubmed | 1.90e-09 | 7 | 96 | 4 | 8464825 | ||
| Pubmed | 1.90e-09 | 7 | 96 | 4 | 27514509 | ||
| Pubmed | 3.78e-09 | 8 | 96 | 4 | 17179145 | ||
| Pubmed | 3.78e-09 | 8 | 96 | 4 | 20610558 | ||
| Pubmed | 3.78e-09 | 8 | 96 | 4 | 18052087 | ||
| Pubmed | 6.79e-09 | 9 | 96 | 4 | 22511988 | ||
| Pubmed | 1.13e-08 | 10 | 96 | 4 | 23642732 | ||
| Pubmed | 1.13e-08 | 10 | 96 | 4 | 11465080 | ||
| Pubmed | 1.13e-08 | 10 | 96 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.13e-08 | 10 | 96 | 4 | 22558097 | |
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 22763696 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 29519853 | ||
| Pubmed | 2.04e-08 | 3 | 96 | 3 | 12847094 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.65e-08 | 12 | 96 | 4 | 20308471 | |
| Pubmed | 2.65e-08 | 12 | 96 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.65e-08 | 12 | 96 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.82e-08 | 13 | 96 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.82e-08 | 13 | 96 | 4 | 25246029 | |
| Pubmed | 5.34e-08 | 14 | 96 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 5.34e-08 | 14 | 96 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 5.34e-08 | 14 | 96 | 4 | 14672974 | |
| Pubmed | 5.34e-08 | 14 | 96 | 4 | 9295054 | ||
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 9.67e-08 | 16 | 96 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.26e-07 | 17 | 96 | 4 | 20639394 | |
| Pubmed | 1.62e-07 | 18 | 96 | 4 | 20056724 | ||
| Pubmed | BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. | 2.03e-07 | 5 | 96 | 3 | 7895173 | |
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 20565459 | ||
| Pubmed | 2.03e-07 | 5 | 96 | 3 | 15057901 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.05e-07 | 19 | 96 | 4 | 23281178 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 5.55e-07 | 24 | 96 | 4 | 24625756 | |
| Pubmed | 1.03e-06 | 190 | 96 | 7 | 24816252 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 1.60e-06 | 203 | 96 | 7 | 16916647 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.69e-06 | 9 | 96 | 3 | 20732626 | |
| Pubmed | 3.31e-06 | 11 | 96 | 3 | 18695635 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25547628 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11901093 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11677206 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22031623 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16488127 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 7.54e-06 | 2 | 96 | 2 | 10497143 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18568343 | ||
| Pubmed | Established and novel Cdk/cyclin complexes regulating the cell cycle and development. | 7.54e-06 | 2 | 96 | 2 | 21630153 | |
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 7.54e-06 | 2 | 96 | 2 | 17603215 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15709193 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12944498 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9647757 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17529886 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20089735 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 36864285 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.92e-05 | 57 | 96 | 4 | 21886157 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 27397516 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19364970 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 16636344 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 2.26e-05 | 3 | 96 | 2 | 30028837 | |
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 2.26e-05 | 3 | 96 | 2 | 20007669 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23721685 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19244109 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18625214 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 26247833 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 2.26e-05 | 3 | 96 | 2 | 24453052 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19225446 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23789755 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17406868 | ||
| Pubmed | Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins. | 2.26e-05 | 3 | 96 | 2 | 34207849 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19996319 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 16397224 | ||
| Pubmed | 3.14e-05 | 441 | 96 | 8 | 12853948 | ||
| Pubmed | 3.45e-05 | 66 | 96 | 4 | 19898482 | ||
| Pubmed | 3.47e-05 | 23 | 96 | 3 | 20696395 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SLC39A1 UGT1A10 UGT1A8 UGT1A7 CNPY4 GPX7 UGT1A9 PRPF6 NDUFA9 AEBP1 CPSF1 LMAN2 SF3B2 PLXNA1 | 4.43e-05 | 1451 | 96 | 14 | 30550785 |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 18946804 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 20147615 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 11306810 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 20628391 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 4.51e-05 | 4 | 96 | 2 | 25518740 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 9271343 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 23700788 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 4.51e-05 | 4 | 96 | 2 | 2108603 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 CLGN PEX1 ECSIT NDUFA9 PTGFRN FEN1 LMAN2 SCRIB OCLN CAPN15 | 5.89e-05 | 942 | 96 | 11 | 31073040 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 7.36e-05 | 498 | 96 | 8 | 36634849 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 7.50e-05 | 5 | 96 | 2 | 18597651 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18556656 | ||
| Pubmed | Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps. | 7.50e-05 | 5 | 96 | 2 | 19838187 | |
| Pubmed | Alcohol dependence and polymorphisms of serotonin-related genes: association studies. | 7.50e-05 | 5 | 96 | 2 | 18405071 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 17072959 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16610949 | ||
| Pubmed | The chromosomal association of condensin II is regulated by a noncatalytic function of PP2A. | 1.12e-04 | 6 | 96 | 2 | 19915589 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.12e-04 | 6 | 96 | 2 | 19204906 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ROCK2 NCAPD3 CLGN SLC39A1 CNPY4 RCN1 PTGFRN CPSF1 LMAN2 SCRIB OSMR PLXNA1 | 1.18e-04 | 1201 | 96 | 12 | 35696571 |
| Pubmed | 1.19e-04 | 172 | 96 | 5 | 27375898 | ||
| Interaction | UGT1A7 interactions | 4.18e-06 | 57 | 85 | 5 | int:UGT1A7 | |
| Interaction | UGT1A9 interactions | 2.01e-05 | 13 | 85 | 3 | int:UGT1A9 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE18 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE7P SPDYE8 SPDYE21 SPDYE5 SPDYE14 SPDYE16 | 8.04e-16 | 271 | 97 | 14 | chr7q11 |
| Cytoband | 7q11.23 | 1.66e-09 | 97 | 97 | 7 | 7q11.23 | |
| Cytoband | 7q22.1 | 1.60e-07 | 113 | 97 | 6 | 7q22.1 | |
| Cytoband | 2q37 | 5.64e-07 | 31 | 97 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 7.57e-06 | 219 | 97 | 6 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.39e-03 | 226 | 97 | 4 | chr2q37 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | SPDYE1 SPDYE9 SPDYE7P SPDYE3 SPDYE2 SPDYE8 SPDYE5 SPDYE2B SPDYE4 SPDYE6 | 2.28e-24 | 12 | 56 | 10 | 756 |
| GeneFamily | UDP glucuronosyltransferases | 2.78e-06 | 32 | 56 | 4 | 363 | |
| GeneFamily | Plexins | 3.35e-04 | 9 | 56 | 2 | 683 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.69e-03 | 76 | 56 | 3 | 743 | |
| GeneFamily | Immunoglobulin like domain containing | 3.00e-03 | 193 | 56 | 4 | 594 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.89e-06 | 182 | 90 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.22e-06 | 187 | 90 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.43e-06 | 190 | 90 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.58e-06 | 192 | 90 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-06 | 196 | 90 | 6 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-06 | 196 | 90 | 6 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 198 | 90 | 6 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-05 | 144 | 90 | 5 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 159 | 90 | 5 | f7803f7b4e0379ae8256ec53110833bedee7db98 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 159 | 90 | 5 | 6e2d38e78d2ef7803e8bb154b5c788bf62a41045 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.91e-05 | 176 | 90 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-05 | 180 | 90 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 4.19e-05 | 190 | 90 | 5 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.19e-05 | 190 | 90 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 191 | 90 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.29e-05 | 191 | 90 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.40e-05 | 192 | 90 | 5 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 4.51e-05 | 193 | 90 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 193 | 90 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 195 | 90 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 195 | 90 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 195 | 90 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | hematopoetic_progenitors-CD34+_MPP|World / Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 851064ca1ab727b4972ad4b72234ee130998a799 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.85e-05 | 196 | 90 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 90 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.09e-05 | 198 | 90 | 5 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.22e-05 | 199 | 90 | 5 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 5.34e-05 | 200 | 90 | 5 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | mLN-(7)_Mast_cell|mLN / shred on region, Cell_type, and subtype | 5.34e-05 | 200 | 90 | 5 | 13bca944fbdbc0be6687eca82c62a4d231ab94f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 130 | 90 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.92e-04 | 141 | 90 | 4 | b2857b73fd754b879b922c7720b5ac3024976822 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-04 | 143 | 90 | 4 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-04 | 143 | 90 | 4 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 57 | 90 | 3 | ade0457d85acaf87fcbeb6ac0d81525bb4a96950 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 57 | 90 | 3 | 0e92c8af66bfdf9de6410c82f404b65b1424e09c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 57 | 90 | 3 | 00083b7c710affa6e24ed495ed46ec6fcea8b676 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 148 | 90 | 4 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 148 | 90 | 4 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.49e-04 | 151 | 90 | 4 | a937e3e5a63bfeb37d2cabb3177760ec583dbf11 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.49e-04 | 151 | 90 | 4 | cba0939a6dd3519f6890695f5b237266ca1a7941 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-04 | 155 | 90 | 4 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-04 | 155 | 90 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.10e-04 | 160 | 90 | 4 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.10e-04 | 160 | 90 | 4 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 162 | 90 | 4 | 9dca585c734faea0e1122c70f5dc36cef3dbd2c6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-04 | 163 | 90 | 4 | 3087224d3f16f5d3aecc3e1e4366220231afe31f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.49e-04 | 165 | 90 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.49e-04 | 165 | 90 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 165 | 90 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 3.57e-04 | 166 | 90 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.65e-04 | 167 | 90 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.69e-04 | 69 | 90 | 3 | 1592edde44c3927d6a2350eb00f92c10d3adf692 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 3.73e-04 | 168 | 90 | 4 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.73e-04 | 168 | 90 | 4 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.73e-04 | 168 | 90 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 3.73e-04 | 168 | 90 | 4 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 3.73e-04 | 168 | 90 | 4 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.73e-04 | 168 | 90 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.82e-04 | 169 | 90 | 4 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.82e-04 | 169 | 90 | 4 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 3.90e-04 | 170 | 90 | 4 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 172 | 90 | 4 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 172 | 90 | 4 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.17e-04 | 173 | 90 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.26e-04 | 174 | 90 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 174 | 90 | 4 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 4.35e-04 | 175 | 90 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.35e-04 | 175 | 90 | 4 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 4.35e-04 | 175 | 90 | 4 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.35e-04 | 175 | 90 | 4 | 4655d3daa95e8ffa7d5ee4180de06b2fec361bfb | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.45e-04 | 176 | 90 | 4 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 176 | 90 | 4 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-04 | 176 | 90 | 4 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-04 | 176 | 90 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.54e-04 | 177 | 90 | 4 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.54e-04 | 177 | 90 | 4 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 4.64e-04 | 178 | 90 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.64e-04 | 178 | 90 | 4 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-04 | 179 | 90 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 4.74e-04 | 179 | 90 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-04 | 179 | 90 | 4 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.84e-04 | 180 | 90 | 4 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.84e-04 | 180 | 90 | 4 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.84e-04 | 180 | 90 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-04 | 180 | 90 | 4 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.84e-04 | 180 | 90 | 4 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-04 | 181 | 90 | 4 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-04 | 181 | 90 | 4 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-04 | 181 | 90 | 4 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-04 | 181 | 90 | 4 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| Drug | naringenin chalcone | 9.91e-10 | 5 | 87 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 9.91e-10 | 5 | 87 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.97e-09 | 6 | 87 | 4 | ctd:C543211 | |
| Drug | alloin | 2.97e-09 | 6 | 87 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.97e-09 | 6 | 87 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 6.90e-09 | 7 | 87 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.38e-08 | 8 | 87 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 2.47e-08 | 9 | 87 | 4 | CID003522271 | |
| Drug | DHPASiU | 2.47e-08 | 9 | 87 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 2.47e-08 | 9 | 87 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 2.47e-08 | 9 | 87 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 2.47e-08 | 9 | 87 | 4 | CID000186631 | |
| Drug | 2,6-dihydroxyanthraquinone | 4.10e-08 | 10 | 87 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 6.43e-08 | 11 | 87 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 6.43e-08 | 11 | 87 | 4 | CID006442661 | |
| Drug | tolcapone | 9.58e-08 | 30 | 87 | 5 | CID004659569 | |
| Drug | N-OH-DABZ | 9.62e-08 | 12 | 87 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 9.62e-08 | 12 | 87 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 9.62e-08 | 12 | 87 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 9.62e-08 | 12 | 87 | 4 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 9.62e-08 | 12 | 87 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 9.62e-08 | 12 | 87 | 4 | CID000160090 | |
| Drug | 4-ethylphenol | 1.14e-07 | 31 | 87 | 5 | CID000031242 | |
| Drug | 2-hydroxyestrone | 1.38e-07 | 13 | 87 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.38e-07 | 13 | 87 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.38e-07 | 13 | 87 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.38e-07 | 13 | 87 | 4 | CID000000411 | |
| Drug | alizarin | 1.38e-07 | 13 | 87 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 1.93e-07 | 14 | 87 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.93e-07 | 14 | 87 | 4 | CID000036401 | |
| Drug | 2-vanillin | 2.15e-07 | 4 | 87 | 3 | ctd:C060843 | |
| Drug | hydratropic acid | 2.15e-07 | 4 | 87 | 3 | ctd:C013025 | |
| Drug | diphenylacetic acid | 2.15e-07 | 4 | 87 | 3 | ctd:C037760 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.63e-07 | 15 | 87 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 2.63e-07 | 15 | 87 | 4 | CID000010752 | |
| Drug | bergamottin | 2.63e-07 | 15 | 87 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 2.63e-07 | 15 | 87 | 4 | CID000543743 | |
| Drug | afloqualone | 2.63e-07 | 15 | 87 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 2.63e-07 | 15 | 87 | 4 | CID000114775 | |
| Drug | NSC-18320 | 2.87e-07 | 37 | 87 | 5 | CID000409070 | |
| Drug | l-borneol | 2.87e-07 | 37 | 87 | 5 | CID000010049 | |
| Drug | AC1L1B6T | 3.30e-07 | 38 | 87 | 5 | CID000001308 | |
| Drug | 1ct8 | 3.31e-07 | 173 | 87 | 8 | CID000444888 | |
| Drug | quercetin-3,4'-diglucoside | 3.49e-07 | 16 | 87 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 3.49e-07 | 16 | 87 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 3.49e-07 | 16 | 87 | 4 | CID005497144 | |
| Drug | 1-phenylimidazole | 3.77e-07 | 39 | 87 | 5 | CID000081595 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 4.56e-07 | 17 | 87 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 4.56e-07 | 17 | 87 | 4 | CID000037766 | |
| Drug | buprenorphine hydrochloride solution | 4.88e-07 | 41 | 87 | 5 | CID000002476 | |
| Drug | isovaleric acid | 5.36e-07 | 5 | 87 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 5.36e-07 | 5 | 87 | 3 | ctd:C012776 | |
| Drug | AC1NFJIQ | 5.52e-07 | 42 | 87 | 5 | CID004659568 | |
| Drug | 5-hydroxytryptophol | 5.52e-07 | 42 | 87 | 5 | CID000009061 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 5.84e-07 | 18 | 87 | 4 | CID000152226 | |
| Drug | Br 2 | 5.84e-07 | 18 | 87 | 4 | CID003060900 | |
| Drug | SureCN12722713 | 5.84e-07 | 18 | 87 | 4 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 5.84e-07 | 18 | 87 | 4 | CID000036614 | |
| Drug | ApApG | 5.84e-07 | 18 | 87 | 4 | CID003081975 | |
| Drug | C1 11-32 | 5.84e-07 | 18 | 87 | 4 | CID000443077 | |
| Drug | C11131 | 5.84e-07 | 18 | 87 | 4 | CID000443076 | |
| Drug | Woodward's reagent K | 6.23e-07 | 43 | 87 | 5 | CID000077804 | |
| Drug | androsterone glucuronide | 6.23e-07 | 43 | 87 | 5 | CID000114833 | |
| Drug | MS-222 | 7.00e-07 | 44 | 87 | 5 | CID000011400 | |
| Drug | almokalant | 7.38e-07 | 19 | 87 | 4 | CID003033962 | |
| Drug | 9-OH-risperidone | 7.38e-07 | 19 | 87 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 7.38e-07 | 19 | 87 | 4 | CID000091433 | |
| Drug | tectochrysin | 9.19e-07 | 20 | 87 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 9.19e-07 | 20 | 87 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 9.19e-07 | 20 | 87 | 4 | CID000116545 | |
| Drug | entacapone | 9.19e-07 | 20 | 87 | 4 | ctd:C071192 | |
| Drug | 3-phenylpropionic acid | 1.07e-06 | 6 | 87 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.07e-06 | 6 | 87 | 3 | ctd:D007216 | |
| Drug | estriol-16-glucuronide | 1.13e-06 | 21 | 87 | 4 | CID000122281 | |
| Drug | dulcin | 1.13e-06 | 21 | 87 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.13e-06 | 21 | 87 | 4 | CID000069186 | |
| Drug | p,p'-hydroxy-DDT | 1.34e-06 | 50 | 87 | 5 | CID000076302 | |
| Drug | scopoletin | 1.34e-06 | 50 | 87 | 5 | CID005280460 | |
| Drug | amonafide | 1.38e-06 | 22 | 87 | 4 | CID000050515 | |
| Drug | plumbagin | 1.38e-06 | 22 | 87 | 4 | ctd:C014758 | |
| Drug | N-methylpiperazine | 1.38e-06 | 22 | 87 | 4 | CID000053167 | |
| Drug | 2-naphthol | 1.53e-06 | 93 | 87 | 6 | CID000008663 | |
| Drug | amidoxime | 1.67e-06 | 23 | 87 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.67e-06 | 23 | 87 | 4 | CID000066651 | |
| Drug | phenanthridine | 1.67e-06 | 23 | 87 | 4 | CID000009189 | |
| Drug | cyproheptadine | 1.84e-06 | 96 | 87 | 6 | CID000002913 | |
| Drug | AS-3201 | 1.99e-06 | 24 | 87 | 4 | CID000153948 | |
| Drug | 5-MOP | 2.37e-06 | 25 | 87 | 4 | CID000002355 | |
| Drug | Hymecromone | 2.37e-06 | 25 | 87 | 4 | ctd:D006923 | |
| Drug | AzMC | 2.37e-06 | 25 | 87 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.37e-06 | 25 | 87 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.37e-06 | 25 | 87 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.37e-06 | 25 | 87 | 4 | CID000013662 | |
| Drug | Thymol | 2.79e-06 | 26 | 87 | 4 | ctd:D013943 | |
| Drug | phenolphthalein | 2.83e-06 | 58 | 87 | 5 | CID000004764 | |
| Drug | glabridin | 2.98e-06 | 8 | 87 | 3 | ctd:C107601 | |
| Drug | Scopoletin | 3.26e-06 | 27 | 87 | 4 | ctd:D012603 | |
| Drug | DiMeIQx | 3.26e-06 | 27 | 87 | 4 | CID000104739 | |
| Drug | licochalcone A | 3.26e-06 | 27 | 87 | 4 | ctd:C070840 | |
| Drug | diflunisal | 3.26e-06 | 27 | 87 | 4 | CID000003059 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.03e-10 | 5 | 76 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 2.03e-10 | 5 | 76 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.03e-10 | 5 | 76 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.41e-09 | 7 | 76 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.82e-09 | 8 | 76 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 5.07e-09 | 9 | 76 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 5.07e-09 | 9 | 76 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 8.43e-09 | 10 | 76 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 8.43e-09 | 10 | 76 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 8.43e-09 | 10 | 76 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 8.43e-09 | 10 | 76 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 1.32e-08 | 11 | 76 | 4 | EFO_0010219 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.64e-08 | 3 | 76 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 1.64e-08 | 3 | 76 | 3 | EFO_0800043 | |
| Disease | biliverdin measurement | 1.98e-08 | 12 | 76 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.98e-08 | 12 | 76 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.85e-08 | 13 | 76 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 2.85e-08 | 13 | 76 | 4 | EFO_0800587 | |
| Disease | X-21441 measurement | 9.43e-08 | 17 | 76 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.43e-08 | 17 | 76 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | cholelithiasis | 1.09e-07 | 88 | 76 | 6 | EFO_0004799 | |
| Disease | angiopoietin-related protein 1 measurement | 1.21e-07 | 18 | 76 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 2.35e-07 | 21 | 76 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 3.27e-07 | 6 | 76 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 7.94e-07 | 28 | 76 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 9.19e-07 | 29 | 76 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.06e-06 | 30 | 76 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 1.94e-06 | 10 | 76 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 2.52e-06 | 37 | 76 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 4.61e-06 | 13 | 76 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement, COVID-19 | 7.88e-06 | 49 | 76 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | gallstones | 8.99e-06 | 108 | 76 | 5 | EFO_0004210 | |
| Disease | urate measurement, spine bone mineral density | 1.55e-05 | 58 | 76 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | thyroxine measurement | 6.40e-05 | 83 | 76 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 6.71e-05 | 84 | 76 | 4 | EFO_0004730 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 3.55e-04 | 11 | 76 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | dodecanedioate measurement | 4.25e-04 | 12 | 76 | 2 | EFO_0021054 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.74e-04 | 147 | 76 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 5.84e-04 | 14 | 76 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Splenomegaly | 1.46e-03 | 22 | 76 | 2 | C0038002 | |
| Disease | attention deficit hyperactivity disorder | 2.22e-03 | 354 | 76 | 5 | EFO_0003888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIPLELWDEPSVEVT | 136 | Q8N129 | |
| KEESPVVSWRLEPED | 21 | Q13072 | |
| EPRKGEELEEEWTPT | 366 | Q8IUX7 | |
| PWIDSITEDPLEAVQ | 771 | O14490 | |
| EENGPEPDWVLSERE | 236 | Q15293 | |
| LEAAPSEAPDVWRIV | 426 | Q99650 | |
| ELEEDWIREYPPITS | 411 | Q16625 | |
| TNPREEPVDTDLIWA | 666 | O75808 | |
| KIPEDEIWQSEPESV | 456 | P27338 | |
| VVQEWQETSPTREEP | 1646 | P78559 | |
| TPDEESIDWTKIEPS | 281 | Q12907 | |
| ALPSETRPLVEAEWE | 71 | Q8N6Q8 | |
| SPEEEEPILWLEFDR | 326 | Q9BZ68 | |
| WTVIAPVRKEEEDNP | 536 | Q10570 | |
| PREVGEESEWEEVII | 406 | Q12766 | |
| EDPTILRIDPEWSIN | 1046 | Q9UIW2 | |
| YVEDPTIVRIEPEWS | 1036 | Q9HCM2 | |
| PPDSDLERVFIWDLD | 316 | Q99502 | |
| VTVEWADPVEEPDPE | 321 | O43390 | |
| EEVTWEPTPSLRFQE | 136 | P03971 | |
| EISPFEPWITRDKVE | 306 | Q16795 | |
| EKEEEEETPPSPWVI | 606 | Q96MC2 | |
| PAPEAEDEEVARRLW | 296 | Q8NBN7 | |
| RWEEELSRQPAVEEP | 156 | P32942 | |
| VAPRFLEVETSWPVD | 226 | P32942 | |
| EIDVVDWTAEGRLVP | 676 | B2RXH4 | |
| KEESPVVSWRLEPED | 21 | Q86Y29 | |
| SESVPEPIVEWVLCD | 186 | P36888 | |
| PEVLDPESVELKWSE | 286 | P39748 | |
| IWSEPSDPVELVVTE | 856 | Q8N6C5 | |
| RSGEWEAVEVLTEEP | 356 | Q3B7J2 | |
| WVITTLELEEEDPGP | 56 | Q8IXH8 | |
| EDREDWVEEPTVLVL | 301 | Q96AY2 | |
| SLEEVPSPVRDVRWD | 371 | O60269 | |
| VGAWDPTVSVEEVRP | 156 | Q96SL4 | |
| KEESPVVSWRLEPED | 21 | Q86Y30 | |
| KEESPVVSWRLEPED | 21 | Q86Y27 | |
| PTDWLTLEDYREPIE | 121 | Q9BPW9 | |
| VEVEPLSADDWEILE | 106 | O43933 | |
| PPEEREVEETPEEWN | 311 | Q9BQ95 | |
| VARDDDPFWDPVEVV | 621 | B7ZC32 | |
| DLEKTWEESDPRTPL | 4031 | Q8TE73 | |
| LEDCVEPAVWVPTEA | 1461 | Q6ZRI0 | |
| ITTDRADDVRPEVTW | 301 | Q9P2B2 | |
| DPIVASEEASEVPLW | 171 | Q9BYH1 | |
| EWTETIRVEEEVAPR | 21 | A2VEC9 | |
| EVTEEEWLSIPEVGD | 151 | O94906 | |
| DKVDEVSTEPIPESW | 196 | O14975 | |
| REDEVVVNDVDLPPW | 2456 | Q8NFP9 | |
| EPEKELAPEPEETWV | 71 | P0DUX0 | |
| EPEKELAPEPEETWV | 71 | P0DTA3 | |
| EPEKELAPEPEETWV | 71 | P0DUD1 | |
| DREIEEGQPEAPWTL | 581 | Q14160 | |
| TEWVETTARELPIPE | 421 | P40967 | |
| RLWRSVIEVPAVPEE | 1366 | Q96QB1 | |
| EPEKELAPEPEETWV | 81 | A6NHP3 | |
| TVPVPGVREEDLIWA | 166 | Q9BR10 | |
| SVLWVSLEEAEPIPD | 446 | P13798 | |
| EEWDERAKIPDPSAV | 276 | O14967 | |
| TVWELDFTETEPLDP | 26 | P42695 | |
| DVLETEDEEPPPRRW | 641 | Q9ULV3 | |
| TATLIDEPTEVDDPW | 56 | O95436 | |
| TKTEEEEIDRTPWGE | 696 | Q13435 | |
| EEIDRTPWGELEPSD | 701 | Q13435 | |
| DRPVEPLDLAVFWVE | 446 | Q9HAW8 | |
| ETVPTWDTIRDEEDV | 1666 | Q6GYQ0 | |
| LNTLDRWIDETPPVD | 116 | Q15257 | |
| EPELLVWRPEAVASE | 6 | Q9NY26 | |
| EPEKELAPEPEETWV | 71 | P0DUX1 | |
| EPEKELAPEPEETWV | 71 | A0A494C0Z2 | |
| EPEKELAPEPEETWV | 71 | P0DUD3 | |
| EPEKELAPEPEETWV | 71 | P0DUD4 | |
| EPEKELAPEPEETWV | 41 | A6NNV3 | |
| EPEKELAPEPEETWV | 71 | P0DUD2 | |
| EPEKELAPEPEETWV | 81 | P0DV79 | |
| EPEKELAPEPEETWV | 81 | A0A494C086 | |
| LAPEPEETWVVETLC | 86 | A0A494C086 | |
| EPEKELAPEPEETWV | 81 | Q495Y8 | |
| KELAPEPEETWVAET | 66 | A6NKU9 | |
| EPEKELAPEPEETWV | 136 | A6NKU9 | |
| EKELAPEPEETWVAE | 211 | A6NKU9 | |
| ELAPEPEETWVAETL | 286 | A6NKU9 | |
| LERAPEPEDTWVVET | 71 | A6NLX3 | |
| EPEKELAPEPEETWV | 81 | A6NIY4 | |
| EPEKELAPEPEETWV | 81 | P0CI01 | |
| RKVLAPEPEEIWVAE | 16 | Q495Y7 | |
| EEDWVLPSEVEVLES | 11 | Q96BH1 | |
| LEEAEDFWPVERGIP | 66 | Q96GC6 | |
| VIWRDLEAESLEPPS | 316 | X6R8R1 | |
| EPEKELAPEPEETWV | 41 | Q8NFV5 | |
| LAPEPEETWVVETLC | 46 | Q8NFV5 | |
| WDNIRETAAPVVPEL | 361 | O75116 | |
| TDEPREEEVEDLISW | 296 | Q5VVX9 | |
| DRPVEPLDLAVFWVE | 446 | O60656 | |
| EELEDVPWFPRKISE | 146 | Q8IWU9 | |
| PIPRVEYTEEETKTW | 206 | Q8IWU9 | |
| RVEPLDEVTTEWSDA | 3316 | Q7Z7G8 | |
| WVDPEDPTVIAETEL | 2296 | Q9Y4G6 | |
| VAEWEEVEPDATRAV | 211 | Q8N3G9 | |
| EPEKELAPEPEETWV | 41 | A6NJR5 | |
| EPEKELAPEPEETWV | 71 | A0A494C191 | |
| EISQVREEEPWVPDI | 286 | O95125 | |
| VPEELSVWIDPFEVS | 86 | Q14106 | |
| DRPVEPLDLAVFWVE | 446 | Q9HAW7 | |
| DTVWDIEEVPRPEGK | 631 | Q9UPQ9 | |
| DRPVEPLDLAVFWVE | 446 | Q9HAW9 | |
| PDPDEVWRSAELTKD | 16 | Q9ULV0 |